knowledge -WSS

knowledge

author：leisure time 2025-10-01 11:02:42 - browse：98

Sen. Rand Paul (C) (R-KY) questions Homeland Security Secretary Alejandro Mayorkas and FBI Director Christopher Wray during a hearing held by the Senate Homeland Security and Governmental Affairs Committee October 31, 2023 in Washington, DC. — Sen. Rand Paul (R-Ky.) Win McNamee/Getty Images

WASHINGTON — A Senate panel Wednesday passed a bill aimed at preventing certain Chinese companies from doing business in the United States. The sole no vote was by Sen. Rand Paul (R-Ky.), who worries that Congress is using anger toward China as a cover for advancing parochial interests.

Many in Congress are worried the Chinese government and military are using the rising dominance of national companies to gather Americans’ genetic information, which could be used for reasons that range from creating bioweapons to giving China a leg up in drug development.

The Biosecure Act, by Homeland Security and Governmental Affairs Chair Gary Peters (D-Mich.), is a response to those concerns. The bill would block the U.S. government from contracting with companies that do business with Chinese “biotechnology companies of concern,” and it names four companies that must be on that list: BGI Genomics, MGI, Complete Genomics, WuXi AppTec, and any subsidiary, parent affiliate, or successor of these companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： What’s missing from the debate over nursing home staff minimums

WSS

AI gets buy

Medicare Advantage plans can’t deny care with AI, CMS warns

Adopting new red light myopia treatments may be short

Wegovy improves function in certain heart failure patients

Top private equity targets in 2023: cardiology, clinical trials, lasers

Unique patient identifier: Experts argue the benefits, pitfalls

Wikipedia

knowledge

leisure time

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A single Democrat is willing to weaken Medicare negotiation power

The high cost of giving birth even with insurance

Abortion policy in the spotlight at Republican debate

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Surgery pushed Ben Carson to fame

Duchenne breakthrough therapy leaves behind pioneering families

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Texas Medical Board asked to define abortion emergency exception

explore

National associations that represent hospice owe an apology

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Readout LOUD: Venture capital, Gilead, and more M&A

Intellia plays down concerns on accidental germline transmission

How the drug

How the first Native Hawaiian psychiatrist helped diversify medicine

Wikipedia

focus

focus

focus